Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-02-20 @ 6:25 PM
Study NCT ID:
NCT02941367
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2016-10-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-04
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-12
First Submit QC Date:
None
Study First Post Date:
2016-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-21
Last Update Post Date:
2022-04-25
Last Update Post Date Type:
ACTUAL